• SORAFENIB TOSYLATE CHEMBL1200485 FDA ApprovedAntineoplastic

    Alternate Names:

    Sorafenib Tosylate
    BAY-54-9085
    Nexavar
    4-{4-[3-(4-CHLORO-3-TRIFLUOROMETHYL-PHENYL)-UREIDO]-PHENOXY} -PYRIDINE-2-CARBOXYLIC ACID METHYLAMIDE-4-METHYLBENZENESULFONATE
    4-{4-[({[4-CHLORO-3-(TRIFLUOROMETHYL)PHENYL]AMINO}CARBONYL)AMINO]PHENOXY}-N -METHYLPYRIDINE-2-CARBOXAMIDE TOSYLATE
    4-{4-[({[4-CHLORO-3-(TRIFLUOROMETHYL)PHENYL]AMINO}CARBONYL)-AMINO]PHENOXY}-N-METHYLPYRIDINE-2-CARBOXAMIDE TOSYLATE
    4-[4-[[4-CHLORO-3-(TRIFLUOROMETHYL)PHENYL]CARBAMOYLAMINO]PHENOXY]-N-METHYLPYRIDINE-2-CARBOXAMIDE; 4-METHYLBENZENESULFONIC ACID
    4-[4-[[4-CHLORANYL-3-(TRIFLUOROMETHYL)PHENYL]CARBAMOYLAMINO]PHENOXY]-N-METHYL-PYRIDINE-2-CARBOXAMIDE; 4-METHYLBENZENESULFONIC ACID
    4-[4-[[[4-CHLORO-3-(TRIFLUOROMETHYL)ANILINO]-OXOMETHYL]AMINO]PHENOXY]-N-METHYL-2-PYRIDINECARBOXAMIDE; 4-METHYLBENZENESULFONIC ACID
    4-[4-({[4-CHLORO-3-(TRIFLUOROMETHYL)PHENYL]CARBAMOYL}AMINO)PHENOXY]-N-METHYLPYRIDINE-2-CARBOXAMIDE 4-METHYLBENZENESULFONATE
    4-(4-(3-(4-CHLORO-3-(TRIFLUOROMETHYL)PHENYL)UREIDO)PHENOXY)-N2-METHYLPYRIDINE-2-CARBOXAMIDE MONO (4-METHYLBENZENESULFONATE)
    4-(4-(3-(4-CHLORO-3-(TRIFLUOROMETHYL)PHENYL)UREIDO)PHENOXY)-N-METHYLPICOLINAMIDE 4-METHYLBENZENESULFONATE
    4-(4-(3-(4-CHLORO-3-(TRIFLUOROMETHYL)PHENYL)UREIDO)PHENOXY)-N-METHYLPICOLINAMIDE TOSYLATE
    Q-201729
    A819449
    SORAFENIB TOSYLATE-SUPPLIED BY SELLECK CHEMICALS
    S-8502
    Q-1222
    D06272
    A20368
    ST24049296
    FT-0698469
    FT-0698449
    FT-0650737
    AM20090612
    LS-186598
    AB0044027
    BCP0726000112
    SMR001339079
    SC-18019
    Q812
    HE344612
    HE072572
    AT-17079
    AK162385
    PARA-TOLUENE SULFONATE SORAFENIB TOSYLATE
    NCGC00167488-08
    RL03773
    CS-0164
    CCG-208000
    AC-6799
    TOX21_112489_1
    SORAFENIB; TOLUENESULFONIC ACID
    SORAFENIB TOSYLATE(BAY 43-9006)/
    AKOS015924650
    HY-10201A
    AR-1G3585
    ABP000935
    TOX21_112489
    AOB87366
    SORAFENIB, P-TOLUENESULFONATE SALT
    HMS2219E08
    5T62Q3B36J
    MOLPORT-006-705-989
    IVDHYUQIDRJSTI-UHFFFAOYSA-N
    MLS002415564
    C28H24CLF3N4O6S
    BAY 43-9006 TOSYLATE
    SORAFENIB TOSILATE (JAN)
    AC1Q5GRN
    AC1L8QVY
    PUBCHEM22488
    S1040_SELLECK
    SORAFENIB (TOSYLATE)
    SORAFENIB - NEXAVAR
    NSC724772
    NEXAVAR (TN)
    NEXAVAR, BAY 43-9006, SORAFENIB TOSYLATE
    CAS-475207-59-1
    2-PYRIDINECARBOXAMIDE, 4-(4-((((4-CHLORO-3-(TRIFLUOROMETHYL)PHENYL)AMINO)CARBONYL)AMINO)PHENOXY)-N-METHYL-, MONO(4-METHYLBENZENESULFONATE)
    1-(4-CHLORO-3-(TRIFLUOROMETHYL)PHENYL)-3-(4-((2-(METHYLCARBAMOYL)PYRIDIN-4-YL)OXY)PHENYL)UREA MONO(4-METHYLBENZENESULFONATE)
    DSSTOX_GSID_47839
    DSSTOX_RID_82581
    DSSTOX_CID_27817
    SORAFENIB TOSYLATE (USAN)
    BAY 54-9085
    ND-0228
    CHEBI:50928
    UNII-5T62Q3B36J
    SORAFENIB TOSYLATE [USAN]
    4-METHYLBENZOLSULFONS
    NEXAVAR(R)
    475207-59-1
    406563

    Drug Info:

    (0 More Sources)

    Publications:

  • Interaction Types:
    inhibitor

    Interaction Info:
    Mechanism of Interaction Stem cell growth factor receptor inhibitor
    Direct Interaction yes

    Publications:

  • Interaction Types:
    inhibitor

    Interaction Info:
    Mechanism of Interaction Vascular endothelial growth factor receptor inhibitor
    Direct Interaction yes

    Publications:

  • Interaction Types:
    inhibitor

    Interaction Info:
    Mechanism of Interaction Tyrosine-protein kinase receptor FLT3 inhibitor
    Direct Interaction yes

    Publications:

  • Interaction Types:
    inhibitor

    Interaction Info:
    Mechanism of Interaction Serine/threonine-protein kinase RAF inhibitor
    Direct Interaction yes

    Publications:

  • Interaction Types:
    inhibitor

    Interaction Info:
    Mechanism of Interaction Platelet-derived growth factor receptor beta inhibitor
    Direct Interaction yes

    Publications:

  • Interaction Types:
    inhibitor

    Interaction Info:
    Mechanism of Interaction Serine/threonine-protein kinase B-raf inhibitor
    Direct Interaction yes

    Publications:

  • Interaction Types:
    inhibitor

    Interaction Info:
    Mechanism of Interaction Vascular endothelial growth factor receptor inhibitor
    Direct Interaction yes

    Publications:

  • Interaction Types:
    inhibitor

    Interaction Info:
    Mechanism of Interaction Vascular endothelial growth factor receptor inhibitor
    Direct Interaction yes

    Publications:

  • Interaction Types:
    inhibitor

    Interaction Info:
    Mechanism of Interaction Tyrosine-protein kinase receptor RET inhibitor
    Direct Interaction yes

    Publications:

  • Interaction Types:
    inhibitor

    Interaction Info:

    Publications:

  • Interaction Types:
    inhibitor

    Interaction Info:

    Publications:

  • Interaction Types:
    inhibitor

    Interaction Info:

    Publications:

  • Interaction Types:
    inhibitor

    Interaction Info:

    Publications: